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The studies employed the cholesterol-fed rabbit model of Alzheimer’s disease (AD) to investigate the relationshipbetween AD-like
neuroﬁbrillarytangle(NFT)neuropathologyandtauprotein levelsasthemaincomponentofNFT.Wemeasuredbrainandplasma
tau levels and semiquantiﬁed NFT-like neuropathology in cholesterol-fed rabbits administered drinking water of varying quality
(distilled, tap, and distilled+copper) compared to animals receiving normal chow and local tap water. Total tau levels in plasma
were increased in all cholesterol-fed rabbits compared to animals on normal chow, regardless of quality of water. In contrast,
increased tau in brain and increased AT8 immunoreactive NFT-like lesions were greatest in cholesterol-fed rabbits administered
distilled water. A substantial decrease in brain tau and incidence and density of AT8 immunoreactive NFT-like lesions occurred in
cholesterol-fed rabbits administered copper water, and an even greater decrease was observed in cholesterol-fed animals on local
tap water. These studies suggest the possibility that circulating tau could be the source of the tau accumulating in the brain.
1.Introduction
One of the neuropathologic features invariably found in
the brains of individuals with Alzheimer’s disease (AD) is
the amyloid-beta (Aβ) containing senile plaque (SP). Blood
samples have been assessed for changes in Aβ levels—driven
by the abundant data that Aβ in the brain was the prime
candidate for precipitating AD. We showed as did others
that circulating levels of the shorter form of Aβ (Aβ40)
increased with decreasing cognitive performance within a
control population. Levels of Aβ40 were increased even
further in mild cognitive impairment (MCI) compared to
controls, and circulating levels of Aβ40 are decreased in AD
compared to MCI [1]. We suggested that gradually increased
production of Aβ occurred with eﬀective clearance from the
brain when individuals change from control to MCI and
that reduced clearance was evidenced as lower circulating Aβ
levels with concurrently increased central accumulation in
the transition from MCI to AD [1].
This is consistent with ﬁndings in the cholesterol-fed
rabbit model of human coronary artery disease where
we identiﬁed numerous neuropathologic features of AD
including central accumulation of Aβ. Early studies were
performed in animals administered a diet containing 2%
cholesterol and tap water for only 8 weeks compared to
animals administered normal rabbit chow and tap water
for a similar length of time [2]. Further studies suggested
that the induction of AD-like Aβ neuropathology by dietary
cholesterol depended on the quality of water the rabbit
was drinking. Animals fed 2% cholesterol and drinking
distilled water showed minimal AD-like neuropathology,
whereas animals drinking tap water were severely aﬀected
[3]. Subsequent studies indicated that it was the copper in
the tap water that produced the diﬀerence in severity of
the cholesterol-produced AD-like Aβ pathology [4]. It was
clear that cholesterol caused the overproduction of Aβ in the
brain and copper inﬂuenced its clearance to the blood via
inhibition of LRP at the vascular interface [5, 6].
Copper has been implicated in the progression and pos-
sibly the cause of AD.Morris et al. haveshown that increased
copper intake signiﬁcantly increases the rate of progression
of AD in the setting of elevated fat intake [7]. A role for2 International Journal of Alzheimer’s Disease
altered copper metabolism as a cause of neurodegenerative
disorders other than AD is clearly recognized [8], and a
role for copperin AD is emerging. Ceruloplasmin transports
85–95% of the copper in human blood [8]. Both copper
and ceruloplasmin levels have been shown to be elevated
in the blood of patients with AD compared to controls by
most [9–13], but not all, investigators [14]. Squitti et al.
have reported a signiﬁcant increase in circulating copper
in AD and a trend for increased ceruloplasmin [15]. These
authors also reported a signiﬁcant negative correlation in
AD between increased copper/ceruloplasmin and decreased
scores on the MMSE, AVLT-A7, and the clock draw [15,
16]. Similar to Squitti’s data, we have shown that there are
signiﬁcant increases in blood copper/ceruloplasmin in AD
comparedtoage-matchedcontrols[1].Moreover,circulating
copper/ceruloplasminlevels increased in controls with lower
performance on the AVLT-A7 and MMSE and remained
elevated in MCI and AD as cognitive ability progressively
deteriorated [1].
Although found in many other tissues of the body
[17], tau protein in brain is the precursor for the other
importantneuropathologicfeatureofAD,theneuroﬁbrillary
tangle (NFT). Speciﬁcally phosphorylated-tau (p-tau) is a
main component of the NFT [18]. Single strands of p-tau
become paired into ﬁlaments called paired helical ﬁlaments
(PHF), which then assemble into ﬁbrillary complexes within
a neuron eventually becoming an NFT. It has been reported
that there are increased tau and 181-p-tau levels in MCI
subjects converting to AD and that levels are stable in
controls and MCI subjects not converting to AD [19].
Although there are reports that the protein tau may have
a copper binding site [20–22], there is only one study
investigating any relationship between the protein tau and
copper in the blood and CSF in AD [16], where a signiﬁcant
positive relationship (P<. 03) between copper levels in
the serum and tau levels in the CSF was identiﬁed in AD
compared to controls. Nevertheless, there are no reports of
changing cognitiveperformance (i.e.,ADversuscontrol)and
a relationship between CSF copper and tau levels or copper
and tau levels in the circulation.
We recently measured total tau in human plasma and
have found signiﬁcant diﬀerences between cognitively nor-
mal individuals, subjects with MCI, and patients with AD
(unpublished observation). Tau levels (total human tau)
were established in each plasma sample using ELISA, kits
and standards purchased from Invitrogen Corp., Camarillo,
CA. The mean circulating tau level (picograms/mL) is
depressed in plasma of patients with AD when compared to
both cognitively normal control and individuals with mild
cognitive impairment (MCI) (P<. 0001 and .0002, resp.).
The mean tau levels were also signiﬁcantly reduced in MCI
compared to control (P = .048),and a signiﬁcant age-related
increase was identiﬁed (P = .042) in the control population
(unpublished observation).
In our previous rabbit studies we administered 2%
cholesterol and varying qualities of drinking water, and we
were able to manipulate Aβ accumulation and memory but
were unable to identify any changes in tau as the major
component of the other characteristic lesion in AD-NFT. A
recent publication indicated that administering lower levels
of dietary cholesterol (1%) over longer periods of time (7
months) could produce NFT-like changes in the brain along
with Aβ deposition in female rabbits [23]. An even more
recent publication found similar features and behavioral
dysfunction in a hypercholesterolemic rat model [24]. Using
thesame methodsemployedinthecurrentstudy,theauthors
noteincreased Aβ,tau,andp-tauinthecortexofcholesterol-
fed rats [24].
Antibodies have been developedto detect diﬀerentstages
of the NFT formation, includingPHF-1 antibody identifying
PHF and AT8 antibody highlighting p-tau [18]. Seven
months of 1% cholesterol diet caused increased PHF-1
immunoreactivity in hippocampus of female rabbits [23]
as well as plaque-like Aβ deposition in the hippocampus
and cortical brain regions [25]. We performed a pilot study
of female rabbits fed 1% cholesterol and drinking distilled
water, copper containing distilled water, or local tap water
compared to animals administered normal chow and tap
water. In this preliminary study we focus on changes in
tau by measuring total tau levels by ELISA and evaluating
the brain for the presence of p-tau by performing AT8
immunohistochemistry.
2.Methods
Twenty female New Zealand White (NZW) rabbits approxi-
mately 2.5 kilograms body weight were obtained, acclimated
to the vivarium for 8–10 days, and assigned to one of
four groups. Fifteen of them were fed 1% Cholesterol
Diet purchased from Purina TestDiet, the remaining ﬁve
were fed normal high-ﬁber chow from Purina LabDiet.
The control animals along with ﬁve of the cholesterol fed
animals were allowed distilled water to drink. Five of the
remaining rabbits received local tap water. and the other
ﬁve were administered distilled water with copper ion added
(0.12PPM copper ion as sulfate). US Filter’s analysis of the
local Sun City tap water used can be seen in a previous
publication [5]. Late in the study, 2 of 5 animals fed the
1% cholesterol chow developed fatty liver disease and/or
severe atherosclerosis. These animals were anesthetized and
perfused with normal saline as soon as symptoms of either
disease appeared. Counter-part animals in the other three
groups were sacriﬁced and similarly processed for tissue
collection. Samples collectedfrom these animals have not yet
been investigated.
Blood samples were collected prior to initiating admin-
istration of the experimental diet and water (baseline). At
the end of 21 weeks (5 months) animals were sacriﬁced
after each rabbitwas deeplyanesthetized with Ketamine (50–
75mg/kg) and Xylazine (5mg/kg) given intramuscularly in
the upper thigh. Additional Ketamine was given at 20%
of the original dose, if it was determined that the animal
was not deep enough. Once the rabbit was anesthetized,
the chest and cranium were shaved, and the animal was
placed on an embalming board. An incision was made over
the sternum and ribs are reﬂected to expose the heart. A
23-gauge vacutainer needle was introduced into the leftInternational Journal of Alzheimer’s Disease 3
ventricle, and 10cc of blood is collected in purple top tubes.
The needle was removed and replaced with a 23-gauge 1.5
inch catheterattached to an IV line. The catheter is advanced
into the left atrium and secured into place using a vascular
clamp. The right atrium is then cut to facilitate drainage
using a pair of Mayo scissors. The rabbit was then perfused
with a minimum of 120 milliliters of sterile saline using a
syringe pump set to deliver 600cc per hour. Once the animal
was perfused, various organs were collected, including the
brain, heart, liver, spleen, and kidneys; half of the brain was
dissected fresh (frontal pole,whole hippocampus), frozenon
d r yi c ea n dt h e ns t o r e da t−70◦C, and the other organs and
half-brain were emersion-ﬁxed in 4% paraformaldehyde.
2.1. Tissue Preparation for ELISA Assays. Brain samples were
homogenized thoroughly in a cold solution (1:8; w:v) of
5M guanidine HCl and 50mM Tris HCl, pH 8.0 using
a Dounce homogenizer. This solution was transferred to
an Eppendorf tube and mixed at room temperature for 3-
4 hours. This sample was diluted 1:50 with a Dulbecco’s
phosphate buﬀered saline with 5% BSA and 0.03% Tween-
20, pH 7.4 supplemented with protease inhibitor cocktail
(Sigma P8340 or Calbiochem no. 539131) at 1mM. This
diluted sample was centrifuged at 16,000g for 20 minutes
at 4◦Cp r i o rt ou s e .Aﬁ f t yμL aliquot of each sample was
assessed in the Tau ELISA assay.
Frozen plasma samples were slowly thawed, and a 20μL
aliquot was diluted 1:10 with undiluted “standard dilution
buﬀe r ”p r o v i d e dw i t he a c hT a uE L I S Ak i t .Aﬁ f t yμL aliquot
of this solution was added to the appropriate well in the
following assay.
2.2. Tau ELISA Assay. Samples were assayed using the ELISA
kit from Invitrogen (#KHB0042). All reagents used were
supplied in the kit including the “standards dilution buﬀer”.
Wash buﬀer was prepared by diluting the supplied con-
centrate 1:25 with puriﬁed water. Standards were prepared
by diluting the supplied standard with “standard dilution
buﬀer” as speciﬁed on labeling to 2000pg/mL. Serial dilu-
tions were made into standard dilution buﬀer to 1000, 500,
250, 125, 62.50, and 31.25pg/mL. 100μLo fs t a n d a r d sw e r e
added to wells in duplicate. 50μL of standard dilution buﬀer
was added to the rest of the wells. 50μLo fs a m p l e( f r e s h
frozen brain or plasma collected in a purple top vacutainer)
was added to ELISA wells in duplicate. The ELISA plate was
covered and incubated for 2 hours at room temperature on
a rotary shaker (1200rpm) and thereafter washed 4 times. A
100μL aliquot of anti-tau detection antibody was added to
each well, and the plate was incubated as above for 1 hour
and thereafter washed 4 times. Antirabbit HRP concentrate
was diluted 100x into HRP diluent and added to wells at
100μL/well, and the plate is incubated for 30 minutes. After
emptyingtheplate100μLofstabilizedchromogenwasadded
to each well, and the uncovered plate was incubated at room
temperature in the dark for 20–30 minutes on the rotary
shaker. The reaction was completed by addition of 100μL
of provided “stop” solution, and the plate was then read at
450nm in a Bio-Tex ELx800 plate reader. Reader software
calculated standard curve, concentration, SD, and CV% (4
parameter algorithm).
2.3. AT8 and Aβ Immunohistochemistry. Blocks of par-
aformaldehyde ﬁxed tissue were aﬃxed to a metal blockwith
superglue, and 50μm vibratome sections were collected and
stored in 4% paraformaldehyde until use. On the ﬁrst day,
50μmt h i c kv i b r a t o m et i s s u es e c t i o n sw e r ew a s h e dt w i c ei n
0.01M Tris Buﬀered Saline (TBS) pH 7.6 for 10 minutes. All
steps were carried out on orbital shaker rotating at about
500rpm. Sections were then transferred to a solution of
3% H2O2 in 0.01M TBSand incubatedatroom temperature
for 30min. Sections were then washed twice for 10 minutes
in 0.01M TBS + 0.1% triton X-100 pH7.6. Sections were
transferred to 88% formic acid for 2-3min and washed
twice for 10 minutes in 0.01M TBS + 0.1% Triton X-100
pH 7.6 and then transferred to antigen retrieval solution
(GeneTex, #GTX28194) for 12–15 minutes. Sections were
washed again and then incubated in 3% horse serum in 0.01
M TBS + 0.1% TritonX-100 pH7.6 for1 hour. Sectionswere
then washed twice for 10 minutes in 0.01M TBS + 0.1%
triton X-100 pH 7.6 and transferred to 1◦ antibody (1:500
dilution of antihuman PHF-Tau AT8 monoclonal antibody-
Pierce Biotechnology or 1:100 dilution of 10D5 antibody to
Aβ—Elan pharmaceuticals) in 0.01 M TBS + 0.1% triton
X-100 pH 7.6) overnight at 4◦C. On the following day the
sections were washed once in 0.01M TBS + 0.1% Triton
X-100 pH 7.6 and transferred to 2◦ antibody (Vectastain
ABC kit PK-6102 mouse IgG, 1 drop/10mL 0.01M TBS +
0.1% Triton X-100 + 1% horse serum) for 1 hour. Then the
sections were washed once in 0.01M TBS + 0.1% Triton X-
100 pH 7.6 and transferred to A/B solution (Vectastain kit,
4 drops A +4 drops B/10mL 0.01M TBS + 0.1% Triton X-
100), washed twice for 10 minutes in 0.05M Tris pH 7.9
and then developed in a diaminobenzidine solution in dark
(15mg DAB + 20μL 30% H2O2 in 100mL 0.05M Tris) for
6–10 minutes. The reaction was stopped by transferring the
sections back into 0.05M Tris pH 7.9. Sections were then
mounted, serially dehydrated, and coverslipped.
2.4. Statistics. Mean tau levels ± SD are present. The
groups were compared for diﬀerences by ANOVA followed
by independent t-test. Although mean diﬀerences were
substantial, the limited number of animals assessed in this
preliminary study precluded signiﬁcance greater than trends
(.05 <P<. 10).
3.Results
We performed a pilot study of long-term dietary cholesterol
in four groups of rabbits. One group was administered
normal chow and tap water, and three groups were admin-
istered 1% cholesterol for ﬁve months. The cholesterol-
fed groups were administered either distilled water, distilled
water supplemented with 0.12PPM copper ion, or local tap
water (routinely containing 0.20PPM copper ion as well as
other trace elements and compounds). Employing methods4 International Journal of Alzheimer’s Disease
Table 1: Tau levels in plasma,whole hippocampus, and frontalcortex, and incidence and density of NFT-like AT8 immunoreactive neurons
inthe frontalandtemporal cortices in rabbitsgrouped according to diet andwaterquality. Thefourgroups of rabbitswere femalerabbitsfed
(1) normal rabbit chow and provided local tap water to drink (Normal chow-tap), (2) 1% cholesterol diet and distilled drinking water (1%
Cholesterol-DW),(3)1%cholesteroldietandcopper supplementeddistilled drinkingwater(1%Cholesterol-DW/Cu),or(4)1%cholesterol
diet and local tap water (1% Cholesterol-tap) for 5 months.
Group Normalchow-tap 1% Cholesterol-DW 1% Cholesterol-DW/Cu 1% Cholesterol-tap
N 33 3 3
Tau level Plasma 24.8 ± 7.73 5 .6 ±3.73 7 .2 ±3.13 4 .4 ± 6.8
Tau level Hippocampus 40.4 ± 11.5 216.1 ±71.3 148.4 ±48.87 1 .8 ± 33.3
Tau level frontal cortex 36.9 ± 15.9 294.2 ±130.66 2 .9 ±1.95 3 .1 ± 32.7
Density of AT8 neurons in
frontal cortex none abundant very few isolated Single faint
Number of animals with
AT8 stained Neurons in
frontal cortex
0o f3 3o f3 2o f3 1o f3
Density of AT8 neurons
Temporal Cortex none Abundant patches of
multiple cells numerous isolated few isolated
Number of Animals with
AT8 neurons in temporal
cortex
0o f3 3o f3 3o f3 2o f3
tomeasure totaltau in human plasma, we measured total tau
levels in plasma, hippocampus, and frontal cortex in each
animal sacriﬁced after 5 months of dietary manipulation.
We also assessed the hippocampus and frontal and temporal
cortex for AT8 staining of p-tau and thefrontal and temporal
cortex for Aβ accumulation (Figure 1,A 4 – D 4 ) .P l a s m a
samples were taken from each animal at baseline and at
sacriﬁce 21 weeks after initiating experimental diet and
controlled diet and water. It is important to note that even
though previous studies administered a 1% cholesterol diet
and puriﬁed water for 7 months [23, 25], we decided to leave
open the possibility of identifying enhanced tau pathology
in animals on copper containing distilled water and/or tap
water and administered experimental diet and drinking
water for only 5 months.
We initially had ﬁve animals in each of the four groups,
but an animal on 1% cholesterol and tap water became ill
after 4 months of diet and was sacriﬁced along with one
animal in each of the other groups. After 4.5 months of
diet another 1% cholesterol and tap water animal became
ill as well as an animal on 1% cholesterol and copper
supplemented distilled water—these two animals and a
counterpart animal in the other 2 groups were sacriﬁced.
Accordingly there were only 3 animals in each group that
completed the 5-month pilot study.
Plasma levels of tau were increased by 40–50% in each of
the cholesterol-fed animal groups after 5 months of experi-
mental dietcompared toanimals on normal rabbitchow and
tap water (Table 1). Tau levels in fresh hippocampus were
5-fold higher in animals administered 1% cholesterol and
distilled water compared to animals on normal rabbit chow
and tap water; levels of tau were 3-fold higher in animals
on 1% cholesterol and copper supplemented distilled water
and less than 2-fold in animals on 1% cholesterol and tap
water (Table 1). A similar graded eﬀect on AT8 staining of p-
tau was glaringly apparent in sections of ﬁxed hippocampus
(Figure 1). In the fascia dentata of the hippocampus AT8
staining is increased dramatically in animals on cholesterol
a n dd i s t i l l e dw a t e r( F i g u r e1,B 1 ) ,i sl e s sp r o n o u n c e di n
the animals on cholesterol and copper (Figure 1,C 1 ) ,a n d
is further reduced in animals on cholesterol and tap water
(Figure 1, D1), all compared to animals on normal chow
and tap water (Figure 1,A 1 ) .T h i si se q u a l l ya p p a r e n tw h e n
viewing the whole hippocampus at low power (Figure 1,4 X ;
A2–D2). These data support the concept that increasing tau
levelsare directly related to the severity and intensity ofAT8-
stained features in the hippocampus. And on the ﬂip side,
the data support the premise that our measured levels of tau
in plasma and brain tissue are valid and accurate. Further
support of this comes from ﬁnding similar graded eﬀects
when assessing frontal cortex. In the frontal cortex we found
a 6-fold increase of tau in animals on 1% cholesterol diet
and distilled water compared to animals fed normal rabbit
chow. In contrast we found a less than 2-fold increase in
tau levels in the frontal cortex of cholesterol-fed animals on
copper-supplementeddistilled waterand tapwater (Table 1).
Identical to the hippocampus, the number and severity of
NFT-like lesions deposits identiﬁed in the frontal cortex
by AT8 staining correlated to the levels of tau measured
(data not shown). AT8 immunoreactive neurons were not
observedinthefrontal cortexofanyanimal onnormalrabbit
chow and tap water. In all of the cholesterol-fed rabbits
Becomes administered distilled water to drink, there were
abundant AT8 stained NFT-like lesions in frontal cortex
(Table 1). The frontal cortex in two of three cholesterol-
fed rabbits drinking copper supplemented distilled water
exhibited a few AT8 stained cells showing ﬁne processes
and considerable arborization (less NFT-like; Table 1). Only
one animal fed cholesterol diet and drinking tap water
showed a single faintly stained AT8 immunoreactive neuron
in the frontal cortex. In the superior temporal cortex no
AT8 immunoreactive neurons were observed in animals fedInternational Journal of Alzheimer’s Disease 5
1% cholesterol diet and
copper-supplemented
distilled drinking water
Control
1% cholesterol
diet and local tap
water
1% cholesterol diet and
distilled drinking water
A-β
10D5
A1
A2
A3
A4
B1
B2
B3
B4
C1
C2
C3
C4
D1
D2
D3
D4
p-tau
AT8
Figure 1: Water quality induced diﬀerences in immunohistochemical staining for phosphorylated tau (p-tau, AT8) and amyloid-beta (Aβ;
10D5) in the brains of cholesterol-fed rabbits compared to animals fed normal control diet. The four groups of rabbits were comprised of
female rabbits fed normal rabbit chow and provided local tap water to drink (A1–A4), 1% cholesterol diet and distilled drinking water (B1–
B4), 1% cholesterol diet and copper supplemented distilled drinking water (C1–C4), or 1% cholesterol diet and local tap water (D1–D4)
for 5 months. Representative p-tau AT8 staining in fascia dentate (A1–D1, 10X), hippocampus (A2–D2, 4X), and superior temporal cortex
(A3–D3, 10X—insets 40X), and Aβ10D5 staining in superior temporal cortex (A4–D4, 10X) are shown.
normal chow and drinking tap water (Table 1;F i g u r e1,A 3 ) ,
but 3 of 3 animals fed 1% cholesterol diet and distilled water
demonstratedabundantAT8immunoreactivefeatureswhich
occurredinpatchesof2-3NFT-likelesions(Table1;Figur e1,
B3).Allthreeofthecholesterol-fedanimalsdrinkingdistilled
water supplemented with copper showed numerous isolated
AT8 stained NFT-like lesions in the superior temporal cortex
(Table 1;F i g u r e1, C3). Two of three animals fed cholesterol
drinkingtapwatershowedveryfewisolatedcellsstainedwith
AT8 antibody (Table 1,F i g u r e1,D 3 ) .
Adjacent sections of hippocampus, and frontal and
temporal cortex were stained for the presence of Aβ using
10D5antibodyemployingthedetailedmethods.Asexpected,
we found that administration of copper containing distilled
water or tap water to drink increased the accumulation of
Aβ in hippocampus (not shown) and frontal cortex (not
shown) and superior temporal cortex (Figure 1,A 4 – D 4 )
of animals fed 1% cholesterol diet compared to animals
drinking unaltered distilled water, as found previously in
rabbit fed 2% cholesterol diet. Similar to ﬁndings in animals
fed 2% cholesterol diet, we observed a graded eﬀect on Aβ
accumulation in animals fed 1% cholesterol diet, with the
greatest Aβ accumulation occurring in animals administered
tap water (Figure 1, D4), somewhat less accumulation in6 International Journal of Alzheimer’s Disease
animals administered copper supplemented distilled water
to drink (Figure 1, C4), while there is minimal Aβ staining
in the superior temporal cortex of animals drinking distilled
water (Figure 1, B4), all compared to animals administered
normal chow and drinking tap water (Figure 1, A4). Overall,
there seemed to be an inverse relationship between neuronal
accumulationofAβandincreasedlevelsoftauandassociated
AT8 immunoreactive NFT-like lesions, based on varying
water quality and region of brain. This disconnect suggests
that accumulation of Aβ may not cause increased levels of
tau,andthatoncesuﬃcientelevationstauoccurinthebrain,
this in turn leads to deposition of p-tau containing NFT-like
lesions.
4.Discussion
This is the ﬁrst study of the eﬀect of intake of copperor trace
metals on levels of the protein tau in the blood and brain.
We have shown that there is increased tau neuropathology
associated with production of increased tau levels in the
blood and brain of the cholesterol fed rabbit. This could be
similar to induction of accelerated aging as these ﬁndings are
consistent with our unpublished observation of age-related
increases in plasma tau levels in cognitively normal humans
coupled with reported increases in the occurrence and
severity of NFT pathology with increasing age in the absence
of dementia [26, 27]. The inverse relationship between tau
and Aβ pathology depending on water quality is diﬃcult to
reconcile when attempting to apply conventional wisdom,
where the accumulation of Aβ containing SP is thought to
precede the occurrence of p-tau containing NFT in AD and
that the processes leading to the formation of the lesions
may be linked. What we may have uncovered is that these
processesmayactuallynotbelinkedatall.Inthischolesterol-
fed rabbit model of Aβ and tau neuropathology, we show
that increased accumulation of Aβ occurs concurrently with
reduced levels of tau and the incidence of AT8 stained
NFT-like lesions. It must be remembered that plaque-only
and NFT-only variants of AD have been reported [28, 29].
Neuropathologic evaluation revealed that most clinically
diagnosed AD patients had both plaques and tangles,
althoughintherare circumstancetherewereindividualswho
had only senile plaques or only NFT in their brains [28, 29].
Coming full circle there are those who would contend that
these individuals were misdiagnosed and those demented
patients with only plaques or tangles did not have AD at
all (William R. Markesbery, personal communication). This
debate continues.
An important feature of animal research is the opportu-
nity to disclose possible mechanisms to explain observations
in human studies. Much of disclosing a likely mechanism
for altered levels of total tau in plasma in relation to tau
concentrationin thebrain would dependon theorigin ofthe
peptide deposited in the brain. If, as all evidence suggests,
Aβ accumulates in the brain with increasing change in the
vasculature, which in turn leads to reduced clearance of
the toxin to the blood [5, 6] and eventually the liver [30],
it is diﬃcult to envision how such an alteration in the
vascular blood brain barrier (BBB) leads to increased levels
of tau and associated formation of NFT-like lesions in the
brain—unless the tau accumulating in brain has its origin
in the blood. Assuming that 1% cholesterol diet increases
tau plasma levels by 40–50% in each cholesterol-fed animal
groups, the question is how this similar increase in blood tau
has diﬀerential eﬀects on tau accumulation in the brain, in
termsoftaulevelsand AT8immunoreactive NFT-likelesions
(5-6 fold increases in the “distilled water” group versus 2-3
fold increases in the “distilled water + copper” group, versus
40% in the “tap water” group)? In other words, the evidence
presented would suggest that reduced BBB permeability
induced by varying water quality attenuates brain uptake of
tau from the blood at the same time it reduces the clearance
of Aβ. Therefore, a normally functioning BBB in animals
administered cholesterol and distilled water allows clearance
of Aβ concomitant with central accumulation of tau due to
a concomitant increase in the concentration of tau in the
blood. By the addition of copper to the distilled drinking
water there is a decrease in BBB permeability leading to
either an increased accumulation of Aβ or a decrease in
tau levels and associated AT8 immunoreactive features in
the brain, while tau concentrations remain elevated to
the same level in general circulation. By further reducing
water quality by administration of tap water there is even
greatercompromise in BBBpermeability and an evengreater
accumulation of Aβ and a greater reduction of tau levels
andAT8immunoreactiveNFT-likelesionsinthebrain,again
whilecirculatingconcentrationsoftauremainelevatedtothe
same level.Accordinglyit can be proposed thattau deposited
in the brain of the cholesterol-fed rabbit model of AD may
have come from the circulation. However, it remains unclear
howaneuronmighttakeupextracellulartauproteinforNFT
formation.
Although provocative, one must keep in mind that these
are preliminary data and as such require replication. Even
so it may be all well and good to be able to induce the
production of NFT-like lesions in the brains of cholesterol-
fed rabbits, but our eventual goal would be much more
important-to ﬁnd a method or medication to make them go
away or not form in the ﬁrst place.
Acknowledgments
This research was funded in part by the Arizona Biomedical
Research Commission (DLS; contract 08-09) the Banner
SHRI Arizona Alzheimer’s Research Center (AGR-2009-
017).
References
[ 1 ]D .L .S p a r k s ,S .P e t a n c e s k a ,M .S a b b a g he ta l . ,“ C h o l e s -
terol, copper and Aβ in controls, MCI, AD and the
AD cholesterol-lowering treatment trial (ADCLT),” Current
Alzheimer Research, vol. 2, no. 5, pp. 527–539, 2005.
[2] D. L. Sparks, “Intraneuronal β-amyloid immunoreactivity in
the CNS,” Neurobiology of Aging, vol. 17, no. 2, pp. 291–299,
1996.International Journal of Alzheimer’s Disease 7
[ 3 ]D .L .S p a r k s ,J .L o c h h e a d ,D .H o r s t m a n ,T .W a g o n e r ,a n dT .
Martin,“Waterqualityhasapronouncedeﬀectoncholesterol-
induced accumulation of Alzheimer amyloid β (Aβ) in rabbit
brain,” Journal of Alzheimer’s Disease, vol. 4, no. 6, pp. 523–
529, 2002.
[4] D. L. Sparks and B. G. Schreurs, “Trace amounts of copper
in water induce β-amyloid plaques and learning deﬁcits in
a rabbit model of Alzheimer’s disease,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 100, no. 19, pp. 11065–11069, 2003.
[5] D. L. Sparks, “The early and ongoing experience with the
cholesterol-fed rabbit as a model of Alzheimer’s disease: the
old, the new and the pilot,” Journal of Alzheimer’s Disease,v o l .
15, no. 4, pp. 641–656, 2008.
[ 6 ]R .D e a n e ,Z .W u ,A .S a g a r ee ta l . ,“ L R P / a m y l o i dβ-peptide
interaction mediates diﬀerential brain eﬄux of Aβ isoforms,”
Neuron, vol. 43, no. 3, pp. 333–344, 2004.
[ 7 ]M .C .M o r r i s ,D .A .E v a n s ,C .C .T a n g n e ye ta l . ,“ D i e t a r y
copperandhighsaturatedandtransfatintakesassociatedwith
cognitive decline,” Archives of Neurology,v o l .6 3 ,n o .8 ,p p .
1085–1088, 2006.
[8] D. J. Waggoner, T. B. Bartnikas, and J. D. Gitlin, “The role of
copper in neurodegenerative disease,” Neurobiology of Disease,
vol. 6, no. 4, pp. 221–230, 1999.
[ 9 ]R .S q u i t t i ,D .L u p o i ,P .P a s q u a l e t t ie ta l . ,“ E l e v a t i o no fs e r u m
copper levels in Alzheimer’s disease,” Neurology,v o l .5 9 ,n o .8 ,
pp. 1153–1161, 2002.
[10] R. Ozcankaya and N. Delibas, “Malondialdehyde, superoxide
dismutase, melatonin, iron, copper, and zinc blood concen-
trations in patients with Alzheimer disease: cross-sectional
study,” Croatian Medical Journal, vol. 43, no. 1, pp. 28–32,
2002.
[11] R. Squitti, P. Pasqualetti, E. Cassetta et al., “Elevation of serum
copper levels discriminates Alzheimer’s disease from vascular
dementia,” Neurology, vol. 60, no. 12, pp. 2013–2014, 2003.
[ 1 2 ] D .S t r a u s a k ,J .F .B .M e r c e r ,H .H .D i e t e r ,W .S t r e m m e l ,a n dG .
Multhaup, “Copper in disorders with neurologicalsymptoms:
Alzheimer’s, Menkes, and Wilson diseases,” Brain Research
Bulletin, vol. 55, no. 2, pp. 175–185, 2001.
[13] S. Bucossi, M. Ventriglia, V. Panetta et al., “Copper in
Alzheimer’s disease: a meta-analysis of serum, plasma, and
cerebrospinal ﬂuid studies,” Journal of Alzheimer’s Disease,v ol.
24, no. 1, pp. 175–185, 2011.
[14] J. Snaedal, J. Kristinsson, S. Gunnarsd´ ottir, ´ A. ´ Olafsd´ ottir, M.
Baldvinsson,andT.J´ ohannesson,“Copper,ceruloplasminand
superoxide dismutase in patients with Alzheimer’s disease.
Ac a s e - c o n t r o ls t u d y , ”Dementia and Geriatric Cognitive
Disorders, vol. 9, no. 5, pp. 239–242, 1998.
[15] R. Squitti, P. Pasqualetti, G. Dal Forno et al., “Excess of serum
copper not related to ceruloplasmin in Alzheimer disease,”
Neurology, vol. 64, no. 6, pp. 1040–1046, 2005.
[ 1 6 ]R .S q u i t t i ,G .B a r b a t i ,L .R o s s ie ta l . ,“ E x c e s so fn o n c e r u l o -
plasmin serum copper in AD correlates with MMSE, CSF β-
amyloid,andh-tau,”Neurology,vol.67,no.1,pp. 76–82,2006.
[17] Y. Gu, F. Oyama, and Y. Ihara, “τ is widely expressed in rat
tissues,” Journal of Neurochemistry, vol. 67, no. 3, pp. 1235–
1244, 1996.
[18] M. Mercken, M. Vandermeeren, U. Lubke et al., “Monoclonal
antibodies with selective speciﬁcity for Alzheimer tau are
directed against phosphatase-sensitive epitopes,” Acta Neu-
ropathologica, vol. 84, no. 3, pp. 265–272, 1992.
[19] D. Strozyk, L. J. Launer, P. A. Adlard et al., “Zinc and copper
modulate Alzheimer Aβ levels in human cerebrospinal ﬂuid,”
Neurobiology of Aging, vol. 30, no. 7, pp. 1069–1077, 2009.
[20] L. M. Sayre, G. Perry, P. L. R. Harris, Y. Liu, K. A. Schubert,
and M. A. Smith,“In situ oxidative catalysisby neuroﬁbrillary
tangles andsenileplaques inAlzheimer’s disease:acentral role
for bound transition metals,” Journal of Neurochemistry,v o l .
74, no. 1, pp. 270–279, 2000.
[21] Q. F. Ma, Y. M. Li, J. T. Du et al., “Binding of copper (II) ion
to an Alzheimer’s tau peptide as revealed by MALDI-TOF MS,
CD, and NMR,” Biopolymers, vol. 79, no. 2, pp. 74–85, 2005.
[22] Q. Ma, Y. Li, J. Du et al., “Copper binding properties of a
tau peptide associatedwithAlzheimer’s diseasestudied by CD,
NMR, andMALDI-TOF MS,” Peptides, vol.27, no.4,pp. 841–
849, 2006.
[23] O. Ghribi, B. Larsen, M. Schrag, and M. M. Herman, “High
cholesterol content in neurons increases BACE, β-amyloid,
and phosphorylated tau levels in rabbit hippocampus,” Exper-
imental Neurology, vol. 200, no. 2, pp. 460–467, 2006.
[24] C. Ullrich, M. Pirchl, and C. Humpel, “Hypercholesterolemia
in rats impairs the cholinergic system and leads to memory
deﬁcits,” Molecular and Cellular Neuroscience,v o l .4 5 ,n o .4 ,
pp. 408–417, 2010.
[ 2 5 ] O .G h r i b i ,M .Y .G o l o v k o ,B .L a r s e n ,M .S c h r a g ,a n dE .J .M u r -
phy, “Deposition of iron and β-amyloid plaques is associated
with cortical cellular damage in rabbits fed with long-term
cholesterol-enriched diets,” Journal of Neurochemistry, vol. 99,
no. 2, pp. 438–449, 2006.
[26] A. L. Guillozet, S. Weintraub, D. C. Mash, and M. Marsel
Mesulam, “Neuroﬁbrillary tangles, amyloid, and memory in
aging and mild cognitive impairment,” Archives of Neurology,
vol. 60, no. 5, pp. 729–736, 2003.
[27] E. Kok, S. Haikonen, T. Luoto et al., “Apolipoprotein E-
dependent accumulation of alzheimer disease-related lesions
begins in middle age,” Annals of Neurology,v o l .6 5 ,n o .6 ,p p .
650–657, 2009.
[28] L.A.Hansen,E.Masliah,D.Galasko,andR.D.Terry, “Plaque-
only Alzheimer disease in usually the Lewy body variant,
and vice versa,” Journal of Neuropathology and Experimental
Neurology, vol. 52, no. 6, pp. 648–654, 1993.
[29] M. Yamada, “Senile dementia of the neuroﬁbrillary tangle
type (tangle-only dementia): neuropathological criteria and
clinical guidelines for diagnosis,” Neuropathology, vol. 23, no.
4, pp. 311–317, 2003.
[30] D. L. Sparks, “Cholesterol metabolism and brain amyloidosis:
evidence for a role of copper in the clearance of Aβ through
the liver,” Current Alzheimer Research, vol. 4, no. 2, pp. 165–
169, 2007.